Home > Insider Trading > Filing (0001209191-13-058259)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
858803	Avanir Pharmaceuticals Inc.	AVNR	Pharmaceutical Preparations (2834)	330314804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1280154	Christine Ocampo	20 Enterprise, Suite 200 Aliso Viejo CA 92656	Vice President, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-12-18	2,450	$2.63	63,202	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,000	Indirect	By Individual Retirement Account
Common Stock	11,900	Indirect	By Spouse

Footnotes

The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The proceeds from the sales will be used to pay required withholdings due by the Reporting Person upon the vesting of 390 and 5,322 Restricted Stock Units on December 15, 2013 and December 17, 2013, respectively. Following the sales reported on this Form 4, the Reporting Person has a total of 287,550 options to purchase shares of common stock that are vested and immediately exercisable and a total of 104,750 options to purchase shares of common stock that have not yet vested. Following the sales reported on this Form 4, the Reporting Person also has 81,881 unvested Restricted Stock Units, of which 15,050 are performance-based Restricted Stock Units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.63 to $2.6312, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.